Gadolinium-based contrast agents (GBCA) are used for contrast-enhanced MRI and may significantly influence image interpretation and clinical decision. Indications for use of GBCAs to enhance the contrast-to-noise ratio in MRI are specific to each subspecialty. The session is organized by the Gadolinium Research and Education Committee of the ESMRMB to present the latest updates on the appropriate use of GBCA in common clinical contexts in neuroradiology and head and neck radiology.
Chairpersons' introduction
Carlo Cosimo Quattrocchi, Trento / Italy
Aart J. Van Der Molen, Leiden / Netherlands
Multiple sclerosis
Alejandro Rovira Cañellas, Barcelona / Spain
Common adult brain tumours
Fabio Martino Doniselli, Milan / Italy
Head and neck cancer
Marco Parillo, Rovereto / Italy
Inner ear and internal auditory canal imaging
Aïna Venkatasamy, Strasbourg / France
Panel discussion: High-relaxivity GBCA and low/reduced GBCA dosing